Empty Capsules Market Size & Growth Forecast 2027–2036, By Segments (Product, End Use, Therapeutic Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Empty Capsules Market size was estimated at USD 4.3 billion in 2026 and is projected to grow at a 3.61% CAGR from 2027 to 2036, reaching USD 6.13 billion by 2036. The industry revenue for 2027 is assessed at USD 4.43 billion.
Get more details on this report
Request Free Sample ReportEmpty Capsules Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to mature pharma and nutraceutical manufacturing, steady capsule demand, and compliance-driven procurement supporting repeat high-volume production and supply stability.
- Asia Pacific is growing at 4.56% CAGR due to expanding manufacturing capacity, rising domestic pharma and supplement output, and increasing export-oriented capsule production demand.
Segment Momentum
- Gelatin accounted for 70.56% of the market in 2026 due to its broad compatibility with pharmaceutical filling processes, consistent performance, and long-standing acceptance in drug and supplement manufacturing.
- Nutraceutical is the fastest-growing end-use segment as rising interest in preventive health and dietary supplements increases demand for flexible, consumer-friendly capsule formats and new product launches.
Market Expansion Drivers
- Growing geriatric population increasing pharmaceutical capsule consumption for chronic disease management.
- Rising nutraceutical and cosmeceutical demand accelerating adoption of fast-dissolving capsule formats.
- Increasing preference for plant-based and specialty capsules supporting product diversification strategies.
Leading Market Participants
- Key players in the empty capsules market include Lonza Group AG (Switzerland), ACG Worldwide (India), Qualicaps Co., Ltd. (Japan), Suheung Co., Ltd. (South Korea), CapsCanada Corporation (Canada), Bright Pharma Caps Inc. (United States), HealthCaps India Ltd. (India), Medi-Caps Ltd. (India), Shanxi JC Biological Technology Co., Ltd. (China), Capsugel Belgium NV (Belgium).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 4.3 billion
- 2027 Estimated Market Size: USD 4.43 billion.
- Projected Market Size: USD 6.13 billion by 2036
- Growth Forecast: 3.61% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Gelatin (Product) | Pharmaceutical (End Use) | Antibiotic and Antibacterial Drugs (Therapeutic Application)
- Emerging Opportunity Segment: Non-Gelatin (Product) | Nutraceutical (End Use) | Vitamins and Dietary Supplements (Therapeutic Application)
Market Growth Drivers and Industry Trends
Growing geriatric population increasing pharmaceutical capsule consumption for chronic disease management
The empty capsules market is benefiting from the expanding geriatric population, which is associated with greater demand for medicines used to manage chronic and age-related conditions. Capsules offer a convenient dosage form for a wide range of pharmaceutical formulations, supporting consistent medication delivery and ease of administration. As long-term treatment requirements increase among older populations, pharmaceutical manufacturers require dependable capsule shells for producing oral medications across different therapeutic categories.
Rising nutraceutical and cosmeceutical demand accelerating adoption of fast-dissolving capsule formats
Rising demand for nutraceutical and cosmeceutical products will boost the empty capsules market as manufacturers seek dosage formats that support convenient and efficient delivery of active ingredients. Fast-dissolving capsules can provide flexibility in formulation and may be suited to products designed for rapid release and consumer convenience. Expanding interest in dietary supplements, beauty-from-within products, and wellness formulations is encouraging manufacturers to adopt specialized capsule formats that align with evolving product requirements.
Increasing preference for plant-based and specialty capsules supporting product diversification strategies
The empty capsules market is increasingly influenced by demand for plant-based and specialty capsule formats as manufacturers respond to changing consumer preferences and formulation requirements. Plant-derived capsule materials can provide alternatives for consumers seeking non-animal-based products, while specialty capsules allow manufacturers to differentiate products through characteristics such as release performance and formulation compatibility. This shift is encouraging capsule producers to broaden their offerings across pharmaceutical, nutraceutical, and specialized consumer health applications.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing geriatric population increasing pharmaceutical capsule consumption for chronic disease management | 1.80% | Moderate | North America, Europe | High | Near Term |
| Rising nutraceutical and cosmeceutical demand accelerating adoption of fast-dissolving capsule formats | 1.50% | Low | Asia Pacific, North America | High | Mid Term |
| Increasing preference for plant-based and specialty capsules supporting product diversification strategies | 1.10% | Moderate | Europe, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America held the largest share of the empty capsules market in 2026, underpinned by a mature pharmaceutical industry, established nutraceutical manufacturing capabilities, and strong demand for oral dosage formulations. Empty capsules provide flexibility for pharmaceutical and supplement producers seeking efficient encapsulation solutions across a wide range of formulations. Advanced manufacturing infrastructure, stringent quality expectations, and sustained development of pharmaceutical and nutritional products continue to support regional demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing regional market, supported by expanding pharmaceutical manufacturing, increasing nutraceutical production, and improving healthcare infrastructure. The region's growing production capabilities are encouraging broader use of capsule-based dosage forms across pharmaceutical and dietary supplement applications. Increasing investments in manufacturing capacity, rising consumer demand for convenient oral formulations, and the development of local healthcare industries are creating favorable conditions for market expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Manufacturing PrecisionGermany emphasizes precision manufacturing and consistent capsule performance to support demanding pharmaceutical production standards. Companies in Germany prioritize reliable capsule quality, material consistency, and compatibility with automated filling technologies across multiple therapeutic applications.
France 🇫🇷
Pharmaceutical Packaging SupportFrance prioritizes empty capsules that meet stringent pharmaceutical quality requirements while supporting diverse dosage formulations. French manufacturers increasingly adopt advanced capsule technologies that improve production efficiency and product consistency throughout manufacturing operations.
Italy 🇮🇹
Nutraceutical Production AlignmentItaly continues strengthening the empty capsules market through growing demand from nutraceutical and dietary supplement manufacturers. Italian producers favor capsule solutions that combine formulation versatility, production efficiency, and compatibility with premium health product development.
Japan 🇯🇵
Premium Capsule QualityJapan continues advancing the empty capsules market through high-performance capsule materials designed for sensitive formulations and premium healthcare products. Japanese manufacturers value dimensional accuracy, product stability, and dependable manufacturing processes for specialized pharmaceutical applications.
South Korea 🇰🇷
Plant-Based Capsule ExpansionSouth Korea is increasing adoption of plant-based empty capsules to support evolving pharmaceutical and nutraceutical formulation strategies. Manufacturers focus on vegetarian alternatives that deliver reliable filling performance while meeting changing consumer and regulatory expectations.
United States 🇺🇸
Formulation FlexibilityThe U.S. empty capsules market prioritizes capsule formats compatible with pharmaceutical and nutraceutical product innovation. Manufacturers increasingly seek high-quality gelatin and plant-based capsules that support efficient production, customized formulations, and evolving consumer preferences.
Segment Leadership and Growth Trends
Empty Capsules Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Gelatin (Largest Segment) vs Non-Gelatin (Fastest-Growing Segment)
Gelatin capsules held the largest share of the empty capsules market, accounting for 70.56% in 2026. Their established use in pharmaceutical formulations, favorable drug-release characteristics, and broad compatibility with active ingredients continue to support strong adoption. Extensive manufacturing capabilities and familiarity among pharmaceutical manufacturers further reinforce gelatin capsules as a dependable delivery format for oral solid dosage products.
Non-gelatin capsules are expanding more rapidly as demand rises for plant-based, vegetarian, and alternative capsule materials. Increasing consumer preference for animal-free formulations, along with growing interest in clean-label and specialized dosage formats, is encouraging pharmaceutical and supplement manufacturers to diversify capsule materials. Improvements in non-gelatin capsule performance and formulation flexibility are further supporting their adoption.
End Use Segment Analysis: Pharmaceutical (Largest Segment) vs Nutraceutical (Fastest-Growing Segment)
The pharmaceutical segment dominated the empty capsules market in 2026, supported by the extensive use of capsules for delivering prescription and over-the-counter medicines. Capsules offer advantages in dose flexibility, formulation convenience, and patient acceptance, making them a widely established dosage form across pharmaceutical applications. Continued development of oral drug formulations and demand for efficient drug-delivery formats are sustaining the segment's strong position.
Nutraceutical applications are growing at a faster pace as consumers increasingly focus on preventive health, nutrition, and wellness-oriented supplementation. Capsules provide a convenient format for vitamins, minerals, herbal ingredients, and other dietary formulations, supporting their broad use across the nutraceutical sector. Rising consumer awareness of functional health products and expanding demand for convenient supplementation are strengthening opportunities for empty capsule manufacturers.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Gelatin, Non-Gelatin | Gelatin | Non-Gelatin |
| End Use | Pharmaceutical, Nutraceutical, Cosmeceutical, Research Laboratories | Pharmaceutical | Nutraceutical |
| Therapeutic Application | Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Antianemic Preparations (Hematenic Preparations), Anti-Inflammatory Drugs, Cardiovascular Therapy Drugs, Cough and Cold Preparations, Others | Antibiotic and Antibacterial Drugs | Vitamins and Dietary Supplements |
Competitive Landscape and Market Positioning
Top players in the empty capsules market:
1. Lonza Group AG (Switzerland)
2. ACG Worldwide (India)
3. Qualicaps Co. Ltd. (Japan)
4. Suheung Co. Ltd. (South Korea)
5. CapsCanada Corporation (Canada)
6. Bright Pharma Caps Inc. (United States)
7. HealthCaps India Ltd. (India)
8. Medi-Caps Ltd. (India)
9. Shanxi JC Biological Technology Co. Ltd. (China)
10. Capsugel Belgium NV (Belgium)
The empty capsules market is experiencing strong innovation focused on improving formulation compatibility and manufacturing efficiency. Manufacturers are introducing plant-based, delayed-release, and customized capsule solutions to address changing pharmaceutical and nutraceutical requirements. Automation in capsule production and advancements in encapsulation technologies are also supporting higher productivity and quality consistency across the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Lonza Group AG (Switzerland) | |||||||
| ACG Worldwide (India) | |||||||
| Qualicaps Co. Ltd. (Japan) | |||||||
| Suheung Co. Ltd. (South Korea) | |||||||
| CapsCanada Corporation (Canada) | |||||||
| Bright Pharma Caps Inc. (United States) | |||||||
| HealthCaps India Ltd. (India) | |||||||
| Medi-Caps Ltd. (India) | |||||||
| Shanxi JC Biological Technology Co. Ltd. (China) | |||||||
| Capsugel Belgium NV (Belgium). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| PSK Pharma | Nov-25 | PSK Pharma commenced commercial production of empty hard gelatin capsules under its proprietary PHARMCAPS brand. This entry marks a strategic expansion of its operational footprint into the specialized pharmaceutical packaging segment, strengthening its vertical integration capabilities. |
| ACG | Oct-25 | ACG announced a USD 200 million investment to establish its first empty-capsule manufacturing plant in the United States. This facility is designed to enhance domestic supply chain security and localize production to meet growing regional demand for high-quality capsule solutions. |
| EMBOCAPS | Oct-24 | EMBOCAPS introduced the EMBOCAPS FLEX, a dual-size capsule technology featuring a versatile locking system. This innovation allows manufacturers to switch between size #00 and #00E specifications on existing machinery, optimizing production flexibility and accommodating varied fill volumes or material densities in pharmaceutical formulations. |
| VANTAGE NUTRITION | Mar-23 | VANTAGE NUTRITION, an ACG company, acquired U.S.-based ComboCap, Inc. and South Africa-based BioCap. The strategic acquisition aims to accelerate the global deployment of advanced encapsulation technologies and expand the company’s geographic manufacturing footprint in North America and emerging international markets. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Empty Capsules Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Capsule Size | Size 000–00, Size 0–1, Size 2–3, Size 4–5 |
| Capsule Release Profile | Immediate-Release, Delayed-Release, Sustained-Release |
| Distribution Channel | Direct Sales, Pharmaceutical & Healthcare Distributors, Online B2B Channels |
Empty Capsules Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Contract Manufacturing and Outsourcing Landscape |
|
| Pharmaceutical Pipeline Demand Mapping |
|
| Sustainability Transition in Capsule Materials |
|
Need a different cut of the data?
Request Custom ResearchHow large is the empty capsules market?
How is the empty capsules industry projected to perform over the next decade?
How are shifting consumer preferences influencing product diversification in the empty capsules market?
Why is demand for fast-dissolving capsule formats increasing in the empty capsules market?
Why does Gelatin lead the empty capsules market?
What is driving growth in the Nutraceutical segment of the empty capsules market?
Why does North America lead the empty capsules market?
What is driving Asia Pacific’s growth in the empty capsules market?
Who holds a significant market share in the empty capsules landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization